Description
PRINCIPIO ACTIVO: HALOPERIDOL
⚙️ Características
00 UI METRONIDAZOL 500
Prevención del rechazo en trasplante hepático (según protocolo)
Ustekinumab 45 mg
AGUA OXIGENADA LASA 750ML PLASMINOGENO TISULAR HUMANO PRINCIPIO ACTIVO: HALOPERIDOL
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
You may also like
recommand products
